OHRP - Perking up here. This might be a $9 target - $10 easily IMO. Ohr Pharmaceutical Announces Positive Interim Top-Line Clinical Results From Phase II Study of Squalamine Eye Drops in Patients With Wet AMD ref. http://finance.yahoo.com/news/ohr-pharmaceutical-announces-positive-interim-110000232.html